Havelund T - Search Results

1

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus.

Broesby-Olsen S, Dybedal I, Gülen T, Kristensen TK, Møller MB, Ackermann L, Sääf M, Karlsson MA, Agertoft L, Brixen K, Hermann P, Stylianou E, Mortz CG, Torfing T, Havelund T, Sander B, Bergström A, Bendix M, Garvey LH, Bjerrum OW, Valent P, Bindslev-Jensen C, Nilsson G, Vestergaard H, Hägglund H. Broesby-Olsen S, et al. Among authors: havelund t. Acta Derm Venereol. 2016 Jun 15;96(5):602-12. doi: 10.2340/00015555-2325. Acta Derm Venereol. 2016. PMID: 26694951 Free article.

2

[Mastocytosis].

Broesby-Olsen S, Kristensen TK, Agertoft L, Møller MB, Hermann AP, Torfing T, Havelund T, Mørtz CG, Bindslev-Jensen C, Vestergaard H. Broesby-Olsen S, et al. Among authors: havelund t. Ugeskr Laeger. 2016 Feb 15;178(7):V10150854. Ugeskr Laeger. 2016. PMID: 27063008 Free article. Review. Danish.

3

Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.

Broesby-Olsen S, Vestergaard H, Mortz CG, Jensen B, Havelund T, Hermann AP, Siebenhaar F, Møller MB, Kristensen TK, Bindslev-Jensen C; Mastocytosis Centre Odense University Hospital (MastOUH). Broesby-Olsen S, et al. Among authors: havelund t. Allergy. 2018 Jan;73(1):230-238. doi: 10.1111/all.13237. Epub 2017 Jul 27. Allergy. 2018. PMID: 28662309

4

Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.

Jarbol DE, Kragstrup J, Stovring H, Havelund T, Schaffalitzky de Muckadell OB. Jarbol DE, et al. Among authors: havelund t. Am J Gastroenterol. 2006 Jun;101(6):1200-8. doi: 10.1111/j.1572-0241.2006.00673.x. Am J Gastroenterol. 2006. PMID: 16771937 Clinical Trial.

5

Ulcerating and stenosing enteropathy treated with misoprostol: a case report with analysis of prostaglandin metabolism.

Havelund T, Jensen BL, Vinholt PJ, Engvad B, Stubbe J. Havelund T, et al. Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1238-41. doi: 10.1097/MEG.0b013e328356bc95. Eur J Gastroenterol Hepatol. 2012. PMID: 22786573

6

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, Lundell L, Pedersen SA, Carlsson R, Junghard O, Stubberöd A, Anker-Hansen O. Havelund T, et al. Am J Gastroenterol. 1999 Jul;94(7):1782-9. doi: 10.1111/j.1572-0241.1999.01206.x. Am J Gastroenterol. 1999. PMID: 10406235 Clinical Trial.

7

Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.

Havelund T, Aalykke C, Rasmussen L. Havelund T, et al. Eur J Gastroenterol Hepatol. 1997 May;9(5):509-14. doi: 10.1097/00042737-199705000-00018. Eur J Gastroenterol Hepatol. 1997. PMID: 9187886 Clinical Trial.

8

Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.

Havelund T, Laursen LS, Lauritsen K. Havelund T, et al. Scand J Gastroenterol Suppl. 1994;201:69-73. doi: 10.3109/00365529409105367. Scand J Gastroenterol Suppl. 1994. PMID: 8047827 Review.

9

[Protein-losing enteropathy caused by a thoracic cyst].

Kinani A, Havelund T, Knudsen T. Kinani A, et al. Among authors: havelund t. Ugeskr Laeger. 2009 Aug 31;171(36):2573-4. Ugeskr Laeger. 2009. PMID: 19732551 Danish.

10

The efficacy of a pectin-based raft-forming anti-reflux agent in endoscopy-negative reflux disease.

Havelund T, Aalykke C. Havelund T, et al. Scand J Gastroenterol. 1997 Aug;32(8):773-7. doi: 10.3109/00365529708996533. Scand J Gastroenterol. 1997. PMID: 9282968 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page